开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2215675, encodeId=d97622156e54a, content=这个杂志接收case吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11951600921, createdName=yj20030610, createdTime=Thu Jul 18 22:52:25 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2176548, encodeId=7def21e6548a8, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：临床研究 经验分享：一审两个半月4个reviewer，给了4个月返修，修回后过了半个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e528556058, createdName=ms3000000737090971, createdTime=Fri Dec 22 14:37:00 CST 2023, time=2023-12-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2148446, encodeId=7c2e2148446b5, content=投的临床研究article 提交之后就是under review 一审差不多2个月 3个审稿人加编辑提了22条意见非常专业刀刀见血同时要求所有作者填写利益申明和版权**文件给的修改时间很长有4个月最终30多天后返修返修后可能没有再送外审 3天后dicision 再3天后二审意见回来要求再补充1篇参考文献当天返修后第2天dicision 第3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5105629822, createdName=ms7000000936770051, createdTime=Mon Jul 17 14:28:06 CST 2023, time=2023-07-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1198460, encodeId=f48f1198460b9, content=审稿速度:1.0 偏重的研究方向：神经外科或介入 经验分享：编辑效率很高，不符合的会秒拒，符合杂志要求的一般会送审，1个月左右意见就会回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=Dr. JC H, createdTime=Tue Mar 01 20:36:30 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886635, encodeId=ca2e8866359f, content=年初，同时期投了两篇，一篇clinical research，一篇technique note。一审周期7-10天，修改后均接收了。但online的时间比较长，要3个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1bd5419608, createdName=ms5000001976267859, createdTime=Sat Sep 19 13:03:29 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091229, encodeId=17352091229db, content=投了两篇临床的回顾性研究。一个under review37天，一个under review17天。同一天变成 decision processing。希望后面有个好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d986442422, createdName=ms2000000174420884, createdTime=Fri Sep 30 19:52:20 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580118, encodeId=4606580118d4, content=这个杂志接收第三通讯的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AWrNt30IeSqXMwcG7uk4iac8Rjewy1FFibZA5jAPDCrPsw1TeWstXtN5hN4TAcl8YzMfYrvh6xFiaUDnOgznjk7eg/132, createdBy=92e72462650, createdName=菲菲mi, createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526493, encodeId=6fe1526493f8, content=额，投了一个case，没报太大希望，10小时后就decision processing了，已经三天了，晕。。。有人知道咋回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=535, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c9c1717462, createdName=Victoria39400192, createdTime=Tue Aug 30 08:30:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076315, encodeId=5ea110e631553, content=审稿速度:1.0 经验分享：投稿27天后审稿意见回来，三个审稿人，意见都很好，给了返修，填写了所有作者的个人信息及利益声明，应该有希望接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=1201d999m84(暂无昵称), createdTime=Thu Dec 02 19:57:13 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921136, encodeId=05a3921136e2, content=期刊推荐审稿人 ① 参考文献作者。选择你写作的论文中引用参考文献的作者，这样审稿人能和你研究内容直接相关，所谓术业有专攻，有相关度才能提高文章的被赏识度和被接受度。 ② 新发表的相关论文作者。这些论文在刚开始研究时可能会有遗漏，挑选新发表的文章的作者，不但可以体现出你对这个研究领域的关注，还能得到较好的审阅，可谓是一举两得。 ③ 学术会议中交流过的学者。学术会议中交流的专家学者一般都在该领域有所建树，无论是对方讨论你的报告，还是你在观摩别人的研究成果后，和对方讨论了双方的相关研究，都会给人留下直观的印象。不懂得，私信我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53462322583, createdName=科研服务站, createdTime=Fri Jan 29 17:16:12 CST 2021, time=2021-01-29, status=1, ipAttribution=)]

2024-07-18 yj20030610 来自江苏省

这个杂志接收case吗？

47 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2215675, encodeId=d97622156e54a, content=这个杂志接收case吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11951600921, createdName=yj20030610, createdTime=Thu Jul 18 22:52:25 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2176548, encodeId=7def21e6548a8, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：临床研究 经验分享：一审两个半月4个reviewer，给了4个月返修，修回后过了半个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e528556058, createdName=ms3000000737090971, createdTime=Fri Dec 22 14:37:00 CST 2023, time=2023-12-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2148446, encodeId=7c2e2148446b5, content=投的临床研究article 提交之后就是under review 一审差不多2个月 3个审稿人加编辑提了22条意见非常专业刀刀见血同时要求所有作者填写利益申明和版权**文件给的修改时间很长有4个月最终30多天后返修返修后可能没有再送外审 3天后dicision 再3天后二审意见回来要求再补充1篇参考文献当天返修后第2天dicision 第3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5105629822, createdName=ms7000000936770051, createdTime=Mon Jul 17 14:28:06 CST 2023, time=2023-07-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1198460, encodeId=f48f1198460b9, content=审稿速度:1.0 偏重的研究方向：神经外科或介入 经验分享：编辑效率很高，不符合的会秒拒，符合杂志要求的一般会送审，1个月左右意见就会回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=Dr. JC H, createdTime=Tue Mar 01 20:36:30 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886635, encodeId=ca2e8866359f, content=年初，同时期投了两篇，一篇clinical research，一篇technique note。一审周期7-10天，修改后均接收了。但online的时间比较长，要3个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1bd5419608, createdName=ms5000001976267859, createdTime=Sat Sep 19 13:03:29 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091229, encodeId=17352091229db, content=投了两篇临床的回顾性研究。一个under review37天，一个under review17天。同一天变成 decision processing。希望后面有个好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d986442422, createdName=ms2000000174420884, createdTime=Fri Sep 30 19:52:20 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580118, encodeId=4606580118d4, content=这个杂志接收第三通讯的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AWrNt30IeSqXMwcG7uk4iac8Rjewy1FFibZA5jAPDCrPsw1TeWstXtN5hN4TAcl8YzMfYrvh6xFiaUDnOgznjk7eg/132, createdBy=92e72462650, createdName=菲菲mi, createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526493, encodeId=6fe1526493f8, content=额，投了一个case，没报太大希望，10小时后就decision processing了，已经三天了，晕。。。有人知道咋回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=535, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c9c1717462, createdName=Victoria39400192, createdTime=Tue Aug 30 08:30:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076315, encodeId=5ea110e631553, content=审稿速度:1.0 经验分享：投稿27天后审稿意见回来，三个审稿人，意见都很好，给了返修，填写了所有作者的个人信息及利益声明，应该有希望接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=1201d999m84(暂无昵称), createdTime=Thu Dec 02 19:57:13 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921136, encodeId=05a3921136e2, content=期刊推荐审稿人 ① 参考文献作者。选择你写作的论文中引用参考文献的作者，这样审稿人能和你研究内容直接相关，所谓术业有专攻，有相关度才能提高文章的被赏识度和被接受度。 ② 新发表的相关论文作者。这些论文在刚开始研究时可能会有遗漏，挑选新发表的文章的作者，不但可以体现出你对这个研究领域的关注，还能得到较好的审阅，可谓是一举两得。 ③ 学术会议中交流过的学者。学术会议中交流的专家学者一般都在该领域有所建树，无论是对方讨论你的报告，还是你在观摩别人的研究成果后，和对方讨论了双方的相关研究，都会给人留下直观的印象。不懂得，私信我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53462322583, createdName=科研服务站, createdTime=Fri Jan 29 17:16:12 CST 2021, time=2021-01-29, status=1, ipAttribution=)]

2023-12-22 ms3000000737090971 来自江西省

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：临床研究
经验分享：一审两个半月4个reviewer，给了4个月返修，修回后过了半个月接收了

83 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2215675, encodeId=d97622156e54a, content=这个杂志接收case吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11951600921, createdName=yj20030610, createdTime=Thu Jul 18 22:52:25 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2176548, encodeId=7def21e6548a8, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：临床研究 经验分享：一审两个半月4个reviewer，给了4个月返修，修回后过了半个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e528556058, createdName=ms3000000737090971, createdTime=Fri Dec 22 14:37:00 CST 2023, time=2023-12-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2148446, encodeId=7c2e2148446b5, content=投的临床研究article 提交之后就是under review 一审差不多2个月 3个审稿人加编辑提了22条意见非常专业刀刀见血同时要求所有作者填写利益申明和版权**文件给的修改时间很长有4个月最终30多天后返修返修后可能没有再送外审 3天后dicision 再3天后二审意见回来要求再补充1篇参考文献当天返修后第2天dicision 第3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5105629822, createdName=ms7000000936770051, createdTime=Mon Jul 17 14:28:06 CST 2023, time=2023-07-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1198460, encodeId=f48f1198460b9, content=审稿速度:1.0 偏重的研究方向：神经外科或介入 经验分享：编辑效率很高，不符合的会秒拒，符合杂志要求的一般会送审，1个月左右意见就会回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=Dr. JC H, createdTime=Tue Mar 01 20:36:30 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886635, encodeId=ca2e8866359f, content=年初，同时期投了两篇，一篇clinical research，一篇technique note。一审周期7-10天，修改后均接收了。但online的时间比较长，要3个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1bd5419608, createdName=ms5000001976267859, createdTime=Sat Sep 19 13:03:29 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091229, encodeId=17352091229db, content=投了两篇临床的回顾性研究。一个under review37天，一个under review17天。同一天变成 decision processing。希望后面有个好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d986442422, createdName=ms2000000174420884, createdTime=Fri Sep 30 19:52:20 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580118, encodeId=4606580118d4, content=这个杂志接收第三通讯的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AWrNt30IeSqXMwcG7uk4iac8Rjewy1FFibZA5jAPDCrPsw1TeWstXtN5hN4TAcl8YzMfYrvh6xFiaUDnOgznjk7eg/132, createdBy=92e72462650, createdName=菲菲mi, createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526493, encodeId=6fe1526493f8, content=额，投了一个case，没报太大希望，10小时后就decision processing了，已经三天了，晕。。。有人知道咋回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=535, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c9c1717462, createdName=Victoria39400192, createdTime=Tue Aug 30 08:30:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076315, encodeId=5ea110e631553, content=审稿速度:1.0 经验分享：投稿27天后审稿意见回来，三个审稿人，意见都很好，给了返修，填写了所有作者的个人信息及利益声明，应该有希望接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=1201d999m84(暂无昵称), createdTime=Thu Dec 02 19:57:13 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921136, encodeId=05a3921136e2, content=期刊推荐审稿人 ① 参考文献作者。选择你写作的论文中引用参考文献的作者，这样审稿人能和你研究内容直接相关，所谓术业有专攻，有相关度才能提高文章的被赏识度和被接受度。 ② 新发表的相关论文作者。这些论文在刚开始研究时可能会有遗漏，挑选新发表的文章的作者，不但可以体现出你对这个研究领域的关注，还能得到较好的审阅，可谓是一举两得。 ③ 学术会议中交流过的学者。学术会议中交流的专家学者一般都在该领域有所建树，无论是对方讨论你的报告，还是你在观摩别人的研究成果后，和对方讨论了双方的相关研究，都会给人留下直观的印象。不懂得，私信我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53462322583, createdName=科研服务站, createdTime=Fri Jan 29 17:16:12 CST 2021, time=2021-01-29, status=1, ipAttribution=)]

2023-07-17 ms7000000936770051 来自重庆

投的临床研究article 提交之后就是under review 一审差不多2个月 3个审稿人加编辑提了22条意见非常专业刀刀见血同时要求所有作者填写利益申明和版权**文件给的修改时间很长有4个月最终30多天后返修返修后可能没有再送外审 3天后dicision 再3天后二审意见回来要求再补充1篇参考文献当天返修后第2天dicision 第3天接收

103 0

[GetPortalCommentsPageByObjectIdResponse(id=2215675, encodeId=d97622156e54a, content=这个杂志接收case吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11951600921, createdName=yj20030610, createdTime=Thu Jul 18 22:52:25 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2176548, encodeId=7def21e6548a8, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：临床研究 经验分享：一审两个半月4个reviewer，给了4个月返修，修回后过了半个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e528556058, createdName=ms3000000737090971, createdTime=Fri Dec 22 14:37:00 CST 2023, time=2023-12-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2148446, encodeId=7c2e2148446b5, content=投的临床研究article 提交之后就是under review 一审差不多2个月 3个审稿人加编辑提了22条意见非常专业刀刀见血同时要求所有作者填写利益申明和版权**文件给的修改时间很长有4个月最终30多天后返修返修后可能没有再送外审 3天后dicision 再3天后二审意见回来要求再补充1篇参考文献当天返修后第2天dicision 第3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5105629822, createdName=ms7000000936770051, createdTime=Mon Jul 17 14:28:06 CST 2023, time=2023-07-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1198460, encodeId=f48f1198460b9, content=审稿速度:1.0 偏重的研究方向：神经外科或介入 经验分享：编辑效率很高，不符合的会秒拒，符合杂志要求的一般会送审，1个月左右意见就会回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=Dr. JC H, createdTime=Tue Mar 01 20:36:30 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886635, encodeId=ca2e8866359f, content=年初，同时期投了两篇，一篇clinical research，一篇technique note。一审周期7-10天，修改后均接收了。但online的时间比较长，要3个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1bd5419608, createdName=ms5000001976267859, createdTime=Sat Sep 19 13:03:29 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091229, encodeId=17352091229db, content=投了两篇临床的回顾性研究。一个under review37天，一个under review17天。同一天变成 decision processing。希望后面有个好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d986442422, createdName=ms2000000174420884, createdTime=Fri Sep 30 19:52:20 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580118, encodeId=4606580118d4, content=这个杂志接收第三通讯的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AWrNt30IeSqXMwcG7uk4iac8Rjewy1FFibZA5jAPDCrPsw1TeWstXtN5hN4TAcl8YzMfYrvh6xFiaUDnOgznjk7eg/132, createdBy=92e72462650, createdName=菲菲mi, createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526493, encodeId=6fe1526493f8, content=额，投了一个case，没报太大希望，10小时后就decision processing了，已经三天了，晕。。。有人知道咋回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=535, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c9c1717462, createdName=Victoria39400192, createdTime=Tue Aug 30 08:30:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076315, encodeId=5ea110e631553, content=审稿速度:1.0 经验分享：投稿27天后审稿意见回来，三个审稿人，意见都很好，给了返修，填写了所有作者的个人信息及利益声明，应该有希望接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=1201d999m84(暂无昵称), createdTime=Thu Dec 02 19:57:13 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921136, encodeId=05a3921136e2, content=期刊推荐审稿人 ① 参考文献作者。选择你写作的论文中引用参考文献的作者，这样审稿人能和你研究内容直接相关，所谓术业有专攻，有相关度才能提高文章的被赏识度和被接受度。 ② 新发表的相关论文作者。这些论文在刚开始研究时可能会有遗漏，挑选新发表的文章的作者，不但可以体现出你对这个研究领域的关注，还能得到较好的审阅，可谓是一举两得。 ③ 学术会议中交流过的学者。学术会议中交流的专家学者一般都在该领域有所建树，无论是对方讨论你的报告，还是你在观摩别人的研究成果后，和对方讨论了双方的相关研究，都会给人留下直观的印象。不懂得，私信我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53462322583, createdName=科研服务站, createdTime=Fri Jan 29 17:16:12 CST 2021, time=2021-01-29, status=1, ipAttribution=)]

2022-03-01 Dr. JC H

审稿速度:1.0
偏重的研究方向：神经外科或介入
经验分享：编辑效率很高，不符合的会秒拒，符合杂志要求的一般会送审，1个月左右意见就会回来

120 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2215675, encodeId=d97622156e54a, content=这个杂志接收case吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11951600921, createdName=yj20030610, createdTime=Thu Jul 18 22:52:25 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2176548, encodeId=7def21e6548a8, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：临床研究 经验分享：一审两个半月4个reviewer，给了4个月返修，修回后过了半个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e528556058, createdName=ms3000000737090971, createdTime=Fri Dec 22 14:37:00 CST 2023, time=2023-12-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2148446, encodeId=7c2e2148446b5, content=投的临床研究article 提交之后就是under review 一审差不多2个月 3个审稿人加编辑提了22条意见非常专业刀刀见血同时要求所有作者填写利益申明和版权**文件给的修改时间很长有4个月最终30多天后返修返修后可能没有再送外审 3天后dicision 再3天后二审意见回来要求再补充1篇参考文献当天返修后第2天dicision 第3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5105629822, createdName=ms7000000936770051, createdTime=Mon Jul 17 14:28:06 CST 2023, time=2023-07-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1198460, encodeId=f48f1198460b9, content=审稿速度:1.0 偏重的研究方向：神经外科或介入 经验分享：编辑效率很高，不符合的会秒拒，符合杂志要求的一般会送审，1个月左右意见就会回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=Dr. JC H, createdTime=Tue Mar 01 20:36:30 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886635, encodeId=ca2e8866359f, content=年初，同时期投了两篇，一篇clinical research，一篇technique note。一审周期7-10天，修改后均接收了。但online的时间比较长，要3个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1bd5419608, createdName=ms5000001976267859, createdTime=Sat Sep 19 13:03:29 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091229, encodeId=17352091229db, content=投了两篇临床的回顾性研究。一个under review37天，一个under review17天。同一天变成 decision processing。希望后面有个好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d986442422, createdName=ms2000000174420884, createdTime=Fri Sep 30 19:52:20 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580118, encodeId=4606580118d4, content=这个杂志接收第三通讯的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AWrNt30IeSqXMwcG7uk4iac8Rjewy1FFibZA5jAPDCrPsw1TeWstXtN5hN4TAcl8YzMfYrvh6xFiaUDnOgznjk7eg/132, createdBy=92e72462650, createdName=菲菲mi, createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526493, encodeId=6fe1526493f8, content=额，投了一个case，没报太大希望，10小时后就decision processing了，已经三天了，晕。。。有人知道咋回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=535, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c9c1717462, createdName=Victoria39400192, createdTime=Tue Aug 30 08:30:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076315, encodeId=5ea110e631553, content=审稿速度:1.0 经验分享：投稿27天后审稿意见回来，三个审稿人，意见都很好，给了返修，填写了所有作者的个人信息及利益声明，应该有希望接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=1201d999m84(暂无昵称), createdTime=Thu Dec 02 19:57:13 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921136, encodeId=05a3921136e2, content=期刊推荐审稿人 ① 参考文献作者。选择你写作的论文中引用参考文献的作者，这样审稿人能和你研究内容直接相关，所谓术业有专攻，有相关度才能提高文章的被赏识度和被接受度。 ② 新发表的相关论文作者。这些论文在刚开始研究时可能会有遗漏，挑选新发表的文章的作者，不但可以体现出你对这个研究领域的关注，还能得到较好的审阅，可谓是一举两得。 ③ 学术会议中交流过的学者。学术会议中交流的专家学者一般都在该领域有所建树，无论是对方讨论你的报告，还是你在观摩别人的研究成果后，和对方讨论了双方的相关研究，都会给人留下直观的印象。不懂得，私信我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53462322583, createdName=科研服务站, createdTime=Fri Jan 29 17:16:12 CST 2021, time=2021-01-29, status=1, ipAttribution=)]

2020-09-19 ms5000001976267859

年初，同时期投了两篇，一篇clinical research，一篇technique note。一审周期7-10天，修改后均接收了。但online的时间比较长，要3个月左右。

239 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2215675, encodeId=d97622156e54a, content=这个杂志接收case吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11951600921, createdName=yj20030610, createdTime=Thu Jul 18 22:52:25 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2176548, encodeId=7def21e6548a8, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：临床研究 经验分享：一审两个半月4个reviewer，给了4个月返修，修回后过了半个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e528556058, createdName=ms3000000737090971, createdTime=Fri Dec 22 14:37:00 CST 2023, time=2023-12-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2148446, encodeId=7c2e2148446b5, content=投的临床研究article 提交之后就是under review 一审差不多2个月 3个审稿人加编辑提了22条意见非常专业刀刀见血同时要求所有作者填写利益申明和版权**文件给的修改时间很长有4个月最终30多天后返修返修后可能没有再送外审 3天后dicision 再3天后二审意见回来要求再补充1篇参考文献当天返修后第2天dicision 第3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5105629822, createdName=ms7000000936770051, createdTime=Mon Jul 17 14:28:06 CST 2023, time=2023-07-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1198460, encodeId=f48f1198460b9, content=审稿速度:1.0 偏重的研究方向：神经外科或介入 经验分享：编辑效率很高，不符合的会秒拒，符合杂志要求的一般会送审，1个月左右意见就会回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=Dr. JC H, createdTime=Tue Mar 01 20:36:30 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886635, encodeId=ca2e8866359f, content=年初，同时期投了两篇，一篇clinical research，一篇technique note。一审周期7-10天，修改后均接收了。但online的时间比较长，要3个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1bd5419608, createdName=ms5000001976267859, createdTime=Sat Sep 19 13:03:29 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091229, encodeId=17352091229db, content=投了两篇临床的回顾性研究。一个under review37天，一个under review17天。同一天变成 decision processing。希望后面有个好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d986442422, createdName=ms2000000174420884, createdTime=Fri Sep 30 19:52:20 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580118, encodeId=4606580118d4, content=这个杂志接收第三通讯的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AWrNt30IeSqXMwcG7uk4iac8Rjewy1FFibZA5jAPDCrPsw1TeWstXtN5hN4TAcl8YzMfYrvh6xFiaUDnOgznjk7eg/132, createdBy=92e72462650, createdName=菲菲mi, createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526493, encodeId=6fe1526493f8, content=额，投了一个case，没报太大希望，10小时后就decision processing了，已经三天了，晕。。。有人知道咋回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=535, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c9c1717462, createdName=Victoria39400192, createdTime=Tue Aug 30 08:30:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076315, encodeId=5ea110e631553, content=审稿速度:1.0 经验分享：投稿27天后审稿意见回来，三个审稿人，意见都很好，给了返修，填写了所有作者的个人信息及利益声明，应该有希望接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=1201d999m84(暂无昵称), createdTime=Thu Dec 02 19:57:13 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921136, encodeId=05a3921136e2, content=期刊推荐审稿人 ① 参考文献作者。选择你写作的论文中引用参考文献的作者，这样审稿人能和你研究内容直接相关，所谓术业有专攻，有相关度才能提高文章的被赏识度和被接受度。 ② 新发表的相关论文作者。这些论文在刚开始研究时可能会有遗漏，挑选新发表的文章的作者，不但可以体现出你对这个研究领域的关注，还能得到较好的审阅，可谓是一举两得。 ③ 学术会议中交流过的学者。学术会议中交流的专家学者一般都在该领域有所建树，无论是对方讨论你的报告，还是你在观摩别人的研究成果后，和对方讨论了双方的相关研究，都会给人留下直观的印象。不懂得，私信我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53462322583, createdName=科研服务站, createdTime=Fri Jan 29 17:16:12 CST 2021, time=2021-01-29, status=1, ipAttribution=)]

2022-09-30 ms2000000174420884

投了两篇临床的回顾性研究。一个under review37天，一个under review17天。同一天变成 decision processing。希望后面有个好的结果。

102 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2215675, encodeId=d97622156e54a, content=这个杂志接收case吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11951600921, createdName=yj20030610, createdTime=Thu Jul 18 22:52:25 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2176548, encodeId=7def21e6548a8, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：临床研究 经验分享：一审两个半月4个reviewer，给了4个月返修，修回后过了半个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e528556058, createdName=ms3000000737090971, createdTime=Fri Dec 22 14:37:00 CST 2023, time=2023-12-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2148446, encodeId=7c2e2148446b5, content=投的临床研究article 提交之后就是under review 一审差不多2个月 3个审稿人加编辑提了22条意见非常专业刀刀见血同时要求所有作者填写利益申明和版权**文件给的修改时间很长有4个月最终30多天后返修返修后可能没有再送外审 3天后dicision 再3天后二审意见回来要求再补充1篇参考文献当天返修后第2天dicision 第3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5105629822, createdName=ms7000000936770051, createdTime=Mon Jul 17 14:28:06 CST 2023, time=2023-07-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1198460, encodeId=f48f1198460b9, content=审稿速度:1.0 偏重的研究方向：神经外科或介入 经验分享：编辑效率很高，不符合的会秒拒，符合杂志要求的一般会送审，1个月左右意见就会回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=Dr. JC H, createdTime=Tue Mar 01 20:36:30 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886635, encodeId=ca2e8866359f, content=年初，同时期投了两篇，一篇clinical research，一篇technique note。一审周期7-10天，修改后均接收了。但online的时间比较长，要3个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1bd5419608, createdName=ms5000001976267859, createdTime=Sat Sep 19 13:03:29 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091229, encodeId=17352091229db, content=投了两篇临床的回顾性研究。一个under review37天，一个under review17天。同一天变成 decision processing。希望后面有个好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d986442422, createdName=ms2000000174420884, createdTime=Fri Sep 30 19:52:20 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580118, encodeId=4606580118d4, content=这个杂志接收第三通讯的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AWrNt30IeSqXMwcG7uk4iac8Rjewy1FFibZA5jAPDCrPsw1TeWstXtN5hN4TAcl8YzMfYrvh6xFiaUDnOgznjk7eg/132, createdBy=92e72462650, createdName=菲菲mi, createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526493, encodeId=6fe1526493f8, content=额，投了一个case，没报太大希望，10小时后就decision processing了，已经三天了，晕。。。有人知道咋回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=535, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c9c1717462, createdName=Victoria39400192, createdTime=Tue Aug 30 08:30:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076315, encodeId=5ea110e631553, content=审稿速度:1.0 经验分享：投稿27天后审稿意见回来，三个审稿人，意见都很好，给了返修，填写了所有作者的个人信息及利益声明，应该有希望接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=1201d999m84(暂无昵称), createdTime=Thu Dec 02 19:57:13 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921136, encodeId=05a3921136e2, content=期刊推荐审稿人 ① 参考文献作者。选择你写作的论文中引用参考文献的作者，这样审稿人能和你研究内容直接相关，所谓术业有专攻，有相关度才能提高文章的被赏识度和被接受度。 ② 新发表的相关论文作者。这些论文在刚开始研究时可能会有遗漏，挑选新发表的文章的作者，不但可以体现出你对这个研究领域的关注，还能得到较好的审阅，可谓是一举两得。 ③ 学术会议中交流过的学者。学术会议中交流的专家学者一般都在该领域有所建树，无论是对方讨论你的报告，还是你在观摩别人的研究成果后，和对方讨论了双方的相关研究，都会给人留下直观的印象。不懂得，私信我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53462322583, createdName=科研服务站, createdTime=Fri Jan 29 17:16:12 CST 2021, time=2021-01-29, status=1, ipAttribution=)]

2019-11-19 菲菲mi

这个杂志接收第三通讯的文章吗？

242 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2215675, encodeId=d97622156e54a, content=这个杂志接收case吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11951600921, createdName=yj20030610, createdTime=Thu Jul 18 22:52:25 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2176548, encodeId=7def21e6548a8, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：临床研究 经验分享：一审两个半月4个reviewer，给了4个月返修，修回后过了半个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e528556058, createdName=ms3000000737090971, createdTime=Fri Dec 22 14:37:00 CST 2023, time=2023-12-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2148446, encodeId=7c2e2148446b5, content=投的临床研究article 提交之后就是under review 一审差不多2个月 3个审稿人加编辑提了22条意见非常专业刀刀见血同时要求所有作者填写利益申明和版权**文件给的修改时间很长有4个月最终30多天后返修返修后可能没有再送外审 3天后dicision 再3天后二审意见回来要求再补充1篇参考文献当天返修后第2天dicision 第3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5105629822, createdName=ms7000000936770051, createdTime=Mon Jul 17 14:28:06 CST 2023, time=2023-07-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1198460, encodeId=f48f1198460b9, content=审稿速度:1.0 偏重的研究方向：神经外科或介入 经验分享：编辑效率很高，不符合的会秒拒，符合杂志要求的一般会送审，1个月左右意见就会回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=Dr. JC H, createdTime=Tue Mar 01 20:36:30 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886635, encodeId=ca2e8866359f, content=年初，同时期投了两篇，一篇clinical research，一篇technique note。一审周期7-10天，修改后均接收了。但online的时间比较长，要3个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1bd5419608, createdName=ms5000001976267859, createdTime=Sat Sep 19 13:03:29 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091229, encodeId=17352091229db, content=投了两篇临床的回顾性研究。一个under review37天，一个under review17天。同一天变成 decision processing。希望后面有个好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d986442422, createdName=ms2000000174420884, createdTime=Fri Sep 30 19:52:20 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580118, encodeId=4606580118d4, content=这个杂志接收第三通讯的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AWrNt30IeSqXMwcG7uk4iac8Rjewy1FFibZA5jAPDCrPsw1TeWstXtN5hN4TAcl8YzMfYrvh6xFiaUDnOgznjk7eg/132, createdBy=92e72462650, createdName=菲菲mi, createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526493, encodeId=6fe1526493f8, content=额，投了一个case，没报太大希望，10小时后就decision processing了，已经三天了，晕。。。有人知道咋回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=535, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c9c1717462, createdName=Victoria39400192, createdTime=Tue Aug 30 08:30:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076315, encodeId=5ea110e631553, content=审稿速度:1.0 经验分享：投稿27天后审稿意见回来，三个审稿人，意见都很好，给了返修，填写了所有作者的个人信息及利益声明，应该有希望接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=1201d999m84(暂无昵称), createdTime=Thu Dec 02 19:57:13 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921136, encodeId=05a3921136e2, content=期刊推荐审稿人 ① 参考文献作者。选择你写作的论文中引用参考文献的作者，这样审稿人能和你研究内容直接相关，所谓术业有专攻，有相关度才能提高文章的被赏识度和被接受度。 ② 新发表的相关论文作者。这些论文在刚开始研究时可能会有遗漏，挑选新发表的文章的作者，不但可以体现出你对这个研究领域的关注，还能得到较好的审阅，可谓是一举两得。 ③ 学术会议中交流过的学者。学术会议中交流的专家学者一般都在该领域有所建树，无论是对方讨论你的报告，还是你在观摩别人的研究成果后，和对方讨论了双方的相关研究，都会给人留下直观的印象。不懂得，私信我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53462322583, createdName=科研服务站, createdTime=Fri Jan 29 17:16:12 CST 2021, time=2021-01-29, status=1, ipAttribution=)]

2016-08-30 Victoria39400192

额，投了一个case，没报太大希望，10小时后就decision processing了，已经三天了，晕。。。有人知道咋回事吗

535 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2215675, encodeId=d97622156e54a, content=这个杂志接收case吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11951600921, createdName=yj20030610, createdTime=Thu Jul 18 22:52:25 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2176548, encodeId=7def21e6548a8, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：临床研究 经验分享：一审两个半月4个reviewer，给了4个月返修，修回后过了半个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e528556058, createdName=ms3000000737090971, createdTime=Fri Dec 22 14:37:00 CST 2023, time=2023-12-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2148446, encodeId=7c2e2148446b5, content=投的临床研究article 提交之后就是under review 一审差不多2个月 3个审稿人加编辑提了22条意见非常专业刀刀见血同时要求所有作者填写利益申明和版权**文件给的修改时间很长有4个月最终30多天后返修返修后可能没有再送外审 3天后dicision 再3天后二审意见回来要求再补充1篇参考文献当天返修后第2天dicision 第3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5105629822, createdName=ms7000000936770051, createdTime=Mon Jul 17 14:28:06 CST 2023, time=2023-07-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1198460, encodeId=f48f1198460b9, content=审稿速度:1.0 偏重的研究方向：神经外科或介入 经验分享：编辑效率很高，不符合的会秒拒，符合杂志要求的一般会送审，1个月左右意见就会回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=Dr. JC H, createdTime=Tue Mar 01 20:36:30 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886635, encodeId=ca2e8866359f, content=年初，同时期投了两篇，一篇clinical research，一篇technique note。一审周期7-10天，修改后均接收了。但online的时间比较长，要3个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1bd5419608, createdName=ms5000001976267859, createdTime=Sat Sep 19 13:03:29 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091229, encodeId=17352091229db, content=投了两篇临床的回顾性研究。一个under review37天，一个under review17天。同一天变成 decision processing。希望后面有个好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d986442422, createdName=ms2000000174420884, createdTime=Fri Sep 30 19:52:20 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580118, encodeId=4606580118d4, content=这个杂志接收第三通讯的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AWrNt30IeSqXMwcG7uk4iac8Rjewy1FFibZA5jAPDCrPsw1TeWstXtN5hN4TAcl8YzMfYrvh6xFiaUDnOgznjk7eg/132, createdBy=92e72462650, createdName=菲菲mi, createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526493, encodeId=6fe1526493f8, content=额，投了一个case，没报太大希望，10小时后就decision processing了，已经三天了，晕。。。有人知道咋回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=535, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c9c1717462, createdName=Victoria39400192, createdTime=Tue Aug 30 08:30:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076315, encodeId=5ea110e631553, content=审稿速度:1.0 经验分享：投稿27天后审稿意见回来，三个审稿人，意见都很好，给了返修，填写了所有作者的个人信息及利益声明，应该有希望接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=1201d999m84(暂无昵称), createdTime=Thu Dec 02 19:57:13 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921136, encodeId=05a3921136e2, content=期刊推荐审稿人 ① 参考文献作者。选择你写作的论文中引用参考文献的作者，这样审稿人能和你研究内容直接相关，所谓术业有专攻，有相关度才能提高文章的被赏识度和被接受度。 ② 新发表的相关论文作者。这些论文在刚开始研究时可能会有遗漏，挑选新发表的文章的作者，不但可以体现出你对这个研究领域的关注，还能得到较好的审阅，可谓是一举两得。 ③ 学术会议中交流过的学者。学术会议中交流的专家学者一般都在该领域有所建树，无论是对方讨论你的报告，还是你在观摩别人的研究成果后，和对方讨论了双方的相关研究，都会给人留下直观的印象。不懂得，私信我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53462322583, createdName=科研服务站, createdTime=Fri Jan 29 17:16:12 CST 2021, time=2021-01-29, status=1, ipAttribution=)]

2021-12-02 1201d999m84(暂无昵称)

审稿速度:1.0
经验分享：投稿27天后审稿意见回来，三个审稿人，意见都很好，给了返修，填写了所有作者的个人信息及利益声明，应该有希望接收

136 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2215675, encodeId=d97622156e54a, content=这个杂志接收case吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11951600921, createdName=yj20030610, createdTime=Thu Jul 18 22:52:25 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2176548, encodeId=7def21e6548a8, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：临床研究 经验分享：一审两个半月4个reviewer，给了4个月返修，修回后过了半个月接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e528556058, createdName=ms3000000737090971, createdTime=Fri Dec 22 14:37:00 CST 2023, time=2023-12-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2148446, encodeId=7c2e2148446b5, content=投的临床研究article 提交之后就是under review 一审差不多2个月 3个审稿人加编辑提了22条意见非常专业刀刀见血同时要求所有作者填写利益申明和版权**文件给的修改时间很长有4个月最终30多天后返修返修后可能没有再送外审 3天后dicision 再3天后二审意见回来要求再补充1篇参考文献当天返修后第2天dicision 第3天接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5105629822, createdName=ms7000000936770051, createdTime=Mon Jul 17 14:28:06 CST 2023, time=2023-07-17, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1198460, encodeId=f48f1198460b9, content=审稿速度:1.0 偏重的研究方向：神经外科或介入 经验分享：编辑效率很高，不符合的会秒拒，符合杂志要求的一般会送审，1个月左右意见就会回来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=Dr. JC H, createdTime=Tue Mar 01 20:36:30 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886635, encodeId=ca2e8866359f, content=年初，同时期投了两篇，一篇clinical research，一篇technique note。一审周期7-10天，修改后均接收了。但online的时间比较长，要3个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1bd5419608, createdName=ms5000001976267859, createdTime=Sat Sep 19 13:03:29 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2091229, encodeId=17352091229db, content=投了两篇临床的回顾性研究。一个under review37天，一个under review17天。同一天变成 decision processing。希望后面有个好的结果。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d986442422, createdName=ms2000000174420884, createdTime=Fri Sep 30 19:52:20 CST 2022, time=2022-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580118, encodeId=4606580118d4, content=这个杂志接收第三通讯的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/AWrNt30IeSqXMwcG7uk4iac8Rjewy1FFibZA5jAPDCrPsw1TeWstXtN5hN4TAcl8YzMfYrvh6xFiaUDnOgznjk7eg/132, createdBy=92e72462650, createdName=菲菲mi, createdTime=Tue Nov 19 00:00:00 CST 2019, time=2019-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526493, encodeId=6fe1526493f8, content=额，投了一个case，没报太大希望，10小时后就decision processing了，已经三天了，晕。。。有人知道咋回事吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=535, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c9c1717462, createdName=Victoria39400192, createdTime=Tue Aug 30 08:30:00 CST 2016, time=2016-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076315, encodeId=5ea110e631553, content=审稿速度:1.0 经验分享：投稿27天后审稿意见回来，三个审稿人，意见都很好，给了返修，填写了所有作者的个人信息及利益声明，应该有希望接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0ba42155144, createdName=1201d999m84(暂无昵称), createdTime=Thu Dec 02 19:57:13 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921136, encodeId=05a3921136e2, content=期刊推荐审稿人 ① 参考文献作者。选择你写作的论文中引用参考文献的作者，这样审稿人能和你研究内容直接相关，所谓术业有专攻，有相关度才能提高文章的被赏识度和被接受度。 ② 新发表的相关论文作者。这些论文在刚开始研究时可能会有遗漏，挑选新发表的文章的作者，不但可以体现出你对这个研究领域的关注，还能得到较好的审阅，可谓是一举两得。 ③ 学术会议中交流过的学者。学术会议中交流的专家学者一般都在该领域有所建树，无论是对方讨论你的报告，还是你在观摩别人的研究成果后，和对方讨论了双方的相关研究，都会给人留下直观的印象。不懂得，私信我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=53462322583, createdName=科研服务站, createdTime=Fri Jan 29 17:16:12 CST 2021, time=2021-01-29, status=1, ipAttribution=)]

2021-01-29 科研服务站

期刊推荐审稿人
① 参考文献作者。选择你写作的论文中引用参考文献的作者，这样审稿人能和你研究内容直接相关，所谓术业有专攻，有相关度才能提高文章的被赏识度和被接受度。 ② 新发表的相关论文作者。这些论文在刚开始研究时可能会有遗漏，挑选新发表的文章的作者，不但可以体现出你对这个研究领域的关注，还能得到较好的审阅，可谓是一举两得。 ③ 学术会议中交流过的学者。学术会议中交流的专家学者一般都在该领域有所建树，无论是对方讨论你的报告，还是你在观摩别人的研究成果后，和对方讨论了双方的相关研究，都会给人留下直观的印象。不懂得，私信我

211 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务